Providers
All 23 in CA
AVALON CARE CENTER-MERCED FRANCISCAN LLC
NPI 1871587964, organization, Merced, CA, Skilled Nursing Facility
3
Evidence tier
network structure with a list link
- Part of provider network D1-00104, ranked 104 nationally.
score 60 of 100, rank 4649, $0 at stake
Provider networks
D1-00104 ranked 10464 providers around Honolulu, HI: 14 hospices, 10 home health agencies, 40 nursing facilities.
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | AVALON CARE CENTER-MERCED FRANCISCAN LLC (also FRANCISCAN POST-ACUTE CARE CENTER) |
| Type | Organization |
| Status | Active |
| NPI issued | September 6, 2005, last updated August 17, 2022 |
| Practice location | 3169 M ST, Merced, CA 95348-2404, 209-722-6231 |
| Mailing address | 206 N 2100 W, Salt Lake City, UT 84116-4740 |
| Authorized official | CHARLES KIRTON (CEO/Chairman) |
| Specialties | Skilled Nursing Facility (314000000X, primary, license 040000192 CA) |
In this area
23 providers in Merced County, CA carry an indicator in the public record, with $30.2M at stake between them. The most common is more hours than a day holds, on 21 of them, followed by paid after a public list action on 1. 1 is tier 1: documented action, then payment.
| tier | provider | at stake | why |
|---|---|---|---|
| 1 | RODOLFO GARCIA Los Banos, CA, ranked 425 | $288 |
|
| 3 | BRISTOL HOSPICE - CALIFORNIA, LLC Merced, CA, ranked 1211 | $338K |
|
| 4 | MIRANDA FURIE Merced, CA, ranked 7284 | $7.6M |
|
| 4 | PRIYANKA JAIN Merced, CA, ranked 7905 | $634K |
|
| 4 | ABHILASHA SHARMA Merced, CA, ranked 7961 | $423K |
|
| 4 | KARTHIKEYA DEVIREDDY Los Banos, CA, ranked 8509 | $3.4M |
|
| 4 | GEORGE ALKHOURI Merced, CA, ranked 8725 | $2.0M |
|
| 4 | ELLEN PIERNOT Merced, CA, ranked 8971 | $1.0M |
|
Recent enforcement in CA
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
DOJPleaded guiltyAug 27, 2026
Anaheim Woman Pleads Guilty to Submitting More Than $2.2 Million in Fraudulent Hospice Care Claims to Medicare
Galbraith submitted approximately $2,266,694 in claims to Medicare for hospice services for beneficiaries who did not have a terminal illness with a life expectancy of six months or less, and Medicare paid her company approximately $2,140,606.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. submitted claims to Medicare for skin cancer tests conducted with an unvalidated positive control range and for tests lacking sufficient patient RNA, and did not retract results or adequately refund Medicare.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. billed Medicare for skin cancer tests conducted using an unvalidated positive control range and for tests with insufficient patient RNA, and did not retract the results or adequately refund Medicare.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4 Million to Settle False Claims Act Lawsuit
Monogram knowingly submitted diagnosis codes in four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to Medicare Advantage Organizations.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4M to Settle False Claims Act Suit
Monogram Health knowingly submitted diagnosis codes within four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to MAOs.
Referral packet
The packet is a draft for a reviewer. It reads every public record behind this case, states what the records show with a citation for each finding, names the regulation each finding relates to, and lists the ordinary explanations to rule out first. It never asserts intent.